Literature DB >> 11310661

Synthesis and anti-influenza virus activity of tricyclic compounds with a unique amine moiety.

M Oka1, Y Ishiwata, N Iwata, N Honda, T Kakigami.   

Abstract

Several novel tricyclic compounds with a unique amine moiety (1, 2a--i) were designed and prepared based on the structure of triperiden for the development of anti-influenza virus agents. An in vitro antiviral assay showed that 1-(1-azabicyclo[3.3.0]octan-5-yl)-1-(4-fluorophenyl)-1-(2-tricyclo[3.3.1.1(3.7)]decyl)methan-1-ol hydrochloride (2f) has a potent anti-influenza A virus activity. Furthermore, since 2f was well tolerated in mice, 2f is promising as a novel anti-influenza virus agent for humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310661     DOI: 10.1248/cpb.49.379

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Design and synthesis of benzenesulfonamide derivatives as potent anti-influenza hemagglutinin inhibitors.

Authors:  Guozhi Tang; Xianfeng Lin; Zongxing Qiu; Wentao Li; Lei Zhu; Lisha Wang; Shaohua Li; Haodong Li; Wenbin Lin; Mei Yang; Tao Guo; Li Chen; Daniel Lee; Jim Z Wu; Wengang Yang
Journal:  ACS Med Chem Lett       Date:  2011-06-07       Impact factor: 4.345

Review 2.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

Review 3.  Small Molecule Inhibitors of Influenza Virus Entry.

Authors:  Zhaoyu Chen; Qinghua Cui; Michael Caffrey; Lijun Rong; Ruikun Du
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18

4.  Inhibition of influenza H7 hemagglutinin-mediated entry.

Authors:  Aleksandar Antanasijevic; Han Cheng; Duncan J Wardrop; Lijun Rong; Michael Caffrey
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.